ArticleFrontiers in cardiovascular medicine2025
Systematic analysis and comparison of the burden of cardiovascular diseases in China from 1990 to 2021 and its 15-year prediction with global levels.
Article in Frontiers in cardiovascular medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- The reliability and quality of short videos as a source of dietary guidance for cardiovascular disease: a cross-sectional study.Frontiers in cardiovascular medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and aims: Systematic assessment of cardiovascular disease (CVD) risk factors is crucial for prevention. We used GBD 2021 data to examine long-term trends and epidemiological features of CVDs in China and globally. Methods and results: CVD prevalence, incidence, mortality, and DALYs were analyzed using joinpoint regression, age-period-cohort models, decomposition, ARIMA, and BAPC. From 1990 to 2021, age-standardized mortality and DALY rates declined, but prevalence and case numbers increased, with males bearing a higher burden. Conclusion: Rapid population aging sustains high CVD burden, highlighting the urgent need for targeted prevention and management strategies.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.